Powered by
Tags
Industrial

Overview

Founded to develop novel therapies for autoimmune conditions, Servatus has grown to become an integrated business combining high potential novel drug discovery, clinical trial execution and manufacturing. We are developing separate platforms for autoimmune treatment with unique modes of action, with an initial focus on rheumatoid arthritis and IBD. Our work in inflammation has extended our clinical pipeline to include candidates for IBS and insomnia. We separately are developing treatments for a variety of skin conditions, including acne, dermatitis and eczema.

Delegates

Nicolas-BW-glare-removed
Nicolas Pichon
General Manager - ABT
Mark Williams
CEO